21.07.2022 | Published by bit.bio

The technology behind Meatable's cultured meat sausage is bit.bio’s opti-ox

Featured Image

bit.bio CEO Mark Kotter (right) with Daan Luining, CTO Meatable, at the October Fest

Today bit.bio sister company Meatable unveiled their first product - a pork sausage made from cultured meat. The technology that made this possible is opit-ox, discovered in bit.bio founder and CEO Mark Kotter’s lab. Mark is also a co-founder of Meatable together with Daan Luining, and Krijn De Nood CTO, and CEO of Meatable.

Welcoming the unveiling of  the company’s first cultured meat sausage product Mark said:

“The milestone announced by Meatable today is significant. It demonstrates the scalability of our technology and enables Meatable to produce enough pork fat and muscle cells to create delicious sausages that are real meat but require zero animal slaughter. This is great news for our planet.

“It’s also great news for the science community as it’s another example of how we can harness the power of biology to build a more sustainable future.

“And it’s good news for bit.bio, the fact that opti-ox technology can be used to create sufficient quantities of porcine cells for cultured meat demonstrates that the same technology will be able to unblock the major bottleneck for therapy - access to a reliable, scalable, consistent supply of cells.”

bit.bio_CIRCLEheadshot_July24-Przemek-Obloj-3
Mark KotterCo-founder and CEO, bit.bio

Read more about the founding of both Meatable and bit.bio from Mark’s perspective in this blog post.

Related pages

About us Coding cells to advance the wellbeing of humanity
Careers See the latest openings
Blog See the latest blogs